Risk of treatment-related esophageal cancer among breast cancer survivors

Annals of Oncology

Volumn 23, Issue 12, 2012, Pages 3081-3091

  Morton, L M ^a   Gilbert, E S ^a   Hall, P ^b   Andersson, M ^c   Joensuu, H ^d   Vaalavirta, L ^d   Dores, G M ^a,e   Stovall, M ^f   Holowaty, E J ^g   Lynch, C F ^h   Curtis, R E ^a   Smith, S A ^f   Kleinerman, R A ^a   Kaijser, M ^b   Storm, H H ⁱ   Pukkala, E ^j   Weathers, R E ^f   Linet, M S ^a   Rajaraman, P ^a   Fraumeni, J F ^a   Brown, L M ^k   Van Leeuwen, F E ^l   Fossa, S D ^m   Johannesen, T B ⁿ   Langmark, F ⁿ   Lamart, S ^a   Travis, L B ^o   Aleman, B M P ^l   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Mental Health Services CPH   (Denmark)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g UNIVERSITY OF TORONTO   (Canada)

^h UNIVERSITY OF IOWA   (United States)

ⁱ DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^j FINNISH CANCER REGISTRY   (Finland)

^k RTI INTERNATIONAL   (United States)

^l NETHERLANDS CANCER INSTITUTE   (Netherlands)

^m OSLO UNIVERSITY HOSPITAL   (Norway)

ⁿ CANCER REGISTRY OF NORWAY   (Norway)

^o UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

more..

Author keywords

Breast cancer; Esophageal cancer; Radiotherapy; Second cancer

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; MELPHALAN; METHOTREXATE; MITOXANTRONE; TAMOXIFEN;

ADENOCARCINOMA; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BREAST SURGERY; CANCER LOCALIZATION; CANCER RISK; CANCER SURVIVOR; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSIMETRY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; FEMALE; HORMONAL THERAPY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; POPULATION RESEARCH; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; SMOKING; SQUAMOUS CELL CARCINOMA; TREATMENT DURATION;

EID: 84869841222     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds144     Document Type: Article

References (42)

1. Jemal A, Bray F, Center MM et al. Global cancer statistics. CA Cancer J Clin 2011; 61(2): 69-90.
2. Clarke M, Collins R, Darby S et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366(9503): 2087-2106.
3. Clarke M, Collins R, Darby S et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365(9472): 1687-1717.
4. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59(4): 225-249.
5. Ahsan H, Neugut AI. Radiation therapy for breast cancer and increased risk for esophageal carcinoma. Ann Intern Med 1998; 128(2): 114-117.
6. Ahsan H, Neugut AI, Gammon MD. Association of adenocarcinoma and squamous cell carcinoma of the esophagus with tobacco-related and other malignancies. Cancer Epidemiol Biomarkers Prev 1997; 6(10): 779-782.
7. Andersson M, Jensen MB, Engholm G et al. Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001. Acta Oncol 2008; 47(4): 755-764.
8. Berrington de Gonzalez A, Curtis RE, Gilbert E et al. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br J Cancer 2010; 102(1): 220-226.
9. Brown LM, Chen BE, Pfeiffer RM et al. Risk of second non-hematological malignancies among 376 825 breast cancer survivors. Breast Cancer Res Treat 2007; 106(3): 439-451.
10. Curtis RE, Ron E, Hankey BF et al. New malignancies following breast cancer. In Curtis RE, Freedman DM, Ron E et al. (eds), New Malignancies among Cancer Survivors: SEER Cancer Registries, 1973-2000. Bethesda, MD: National Cancer Institute [NIH Publ. No. 05-5302] 2006; 181-206.
11. Das A, Thomas S, Zablotska LB et al. Association of esophageal adenocarcinoma with other subsequent primary cancers. J Clin Gastroenterol 2006; 40(5): 405-411.
12. Evans HS, Lewis CM, Robinson D et al. Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. Br J Cancer 2001; 84(3): 435-440.
13. Lee KD, Chen SC, Chan CH et al. Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan. Cancer Epidemiol Biomarkers Prev 2008; 17 (10): 2647-2655.
14. Levi F, Handimbison L, Te VC et al. Increased risk of esophageal cancer after breast cancer. Ann Oncol 2005; 16(11): 1829-1831.
15. Mellemkjaer L, Friis S, Olsen JH et al. Risk of second cancer among women with breast cancer. Int J Cancer 2006; 118(9): 2285-2292.
16. Roychoudhuri R, Evans H, Robinson D et al. Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer 2004; 91(5): 868-872.
17. Salminen EK, Pukkala E, Kiel KD et al. Impact of radiotherapy in the risk of esophageal cancer as subsequent primary cancer after breast cancer. Int J Radiat Oncol Biol Phys 2006; 65(3): 699-704.
18. Schaapveld M, Visser O, Louwman MJ et al. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. J Clin Oncol 2008; 26(8): 1239-1246.
19. van Halteren HK, Taal BG, van Tinteren H et al. Risk factors for the development of oesophageal cancer as a second primary tumour. Eur J Cancer 1995; 31(11): 1836-1839.
20. Zablotska LB, Chak A, Das A et al. Increased risk of squamous cell esophageal cancer after adjuvant radiation therapy for primary breast cancer. Am J Epidemiol 2005; 161(4): 330-337.
21. Maddams J, Parkin DM, Darby SC. The cancer burden in the UK in 2007 due to radiotherapy. Int J Cancer 2011 [epub ahead of print June 13].
22. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349(23): 2241-2252.
23. Freedman ND, Abnet CC, Leitzmann MF et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol 2007; 165(12): 1424-1433.
24. Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15(5): 872-878.
25. Breslow NE, Day NE. Statistical Methods in Cancer Research: Volume 1 - The Analysis of Case-Control Studies. Lyon: International Agency for Research on Cancer 1980.
26. Stovall M, Weathers R, Kasper C et al. Dose reconstruction for therapeutic and diagnostic radiation exposures: use in epidemiological studies. Radiat Res 2006; 166(1): 141-157.
27. Perez CA, Brady LW, Halperin EC et al. Principles and Practice of Radiation Oncology, 5th edition. Philadelphia: Lippincott Williams & Wilkins 2008.
28. United Nations. Effects of ionizing radiation: United Nations Scientific Committee on the Effects of Atomic Radiation - UNSCEAR 2006 Report, Volume 1 - Report to the General Assembly, with Scientific Annexes A and B. Vienna: United Nations 2008.
29. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence - SEER 17 Regs Limited-Use + Hurricane Katrina Impacted Louisiana Cases, Nov. 2007 Sub (2000-2005): National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on the November 2007 submission; 2008; www.seer.cancer.gov.
30. Weiss HA, Darby SC, Doll R. Cancer mortality following X-ray treatment for ankylosing spondylitis. Int J Cancer 1994; 59(3): 327-338.
31. Preston DL, Ron E, Tokuoka S et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 2007; 168(1): 1-64.
32. Taylor CW, Nisbet A, McGale P et al. Cardiac exposures in breast cancer radiotherapy: 1950s-1990s. Int J Radiat Oncol Biol Phys 2007; 69(5): 1484-1495.
33. Hurkmans CW, Saarnak AE, Pieters BR et al. An improved technique for breast cancer irradiation including the locoregional lymph nodes. Int J Radiat Oncol Biol Phys 2000; 47(5): 1421-1429.
34. Travis LB, Gospodarowicz M, Curtis RE et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 2002; 94(3): 182-192.
35. Emadi A, Jones RJ, Brodsky RA. Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol 2009; 6(11): 638-647.
36. Gurski R, Schirmer C, Kruel C et al. Induction of esophageal carcinogenesis by diethylnitrosamine and assessment of the promoting effect of ethanol and N-nitrosonornicotine: experimental model in mice. Dis Esophagus 1999; 12(2): 99-105.
37. Zgodzinski W, Zinkiewicz K, Juskiewicz W et al. Diethylnitrosamine may induce esophageal dysplasia after local intramural administration. Rocz Akad Med Bialymst 2003; 48: 48-51.
38. Hogan AM, Collins D, Baird AW et al. Estrogen and gastrointestinal malignancy. Mol Cell Endocrinol 2009; 307(1-2): 19-24.
39. Curtis RE, Boice JD, Jr, Shriner DA et al. Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst 1996; 88(12): 832-834.
40. Gilbert ES, Stovall M, Gospodarowicz M et al. Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res 2003; 159(2): 161-173.
41. Kaufman EL, Jacobson JS, Hershman DL et al. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol 2008; 26(3): 392-398.
42. Rampado S, Ruol A, Guido M et al. Mediastinal carcinosis involving the esophagus in breast cancer: the "breast-esophagus" syndrome: report on 25 cases and guidelines for diagnosis and treatment. Ann Surg 2007; 246(2): 316-322.